Research Roundup


20191453 - idea concept with light bulbs and energy save bulb green background

Debbie Rigby takes a look at the latest in research news

Penicillin allergy

Penicillin allergy is commonly reported, but 9 out of 10 times, penicillin will be tolerated if administered. Reasons for this include mislabelling intolerances as allergies and waning of immunoglobulin E–mediated allergy over time. Penicillin allergy is lost over time, with resolution in 80% of people over 10 years, and in 50% over 5 years.

CMAJ 2019 February 25;191:E231.

Commentary

Podcast

 

Patterns of high-risk prescribing and other factors in relation to receipt of a home medicines review

Prospective cohort analysis of over 130,000 participants shows HMR use over a 5-year period was generally below 10%, even in high-risk groups. HMR use was 1.5% in people using <5 medications at baseline, 6.8% with 5–9 medications, 12.7% with ≥10 medications, 8.8% using Narrow Therapeutic Index medicines, 6.8% using Beers Criteria potentially inappropriate medicines and 7.4% using DBI medicines. The authors suggest substantial potential for improvement in uptake and targeting.

BMJ Open 2019;9:e027305.
Commentary

 

Vitamin D to prevent exacerbations of COPD

A systematic review and meta-analysis of individual participant data from 4 randomised controlled trials (n=560) shows vitamin D supplementation safely and substantially reduced the rate of moderate/severe COPD exacerbations in patients with baseline 25-hydroxyvitamin D levels <25 nmol/L but not in those with higher levels.

Thorax 2019;74(4):337-45.

 

Evaluation of a pharmacist-led penicillin allergy de-labelling ward round

Antibiotic allergy labels (AALs), reported by up to 25% of hospitalized patients, are a significant barrier to appropriate prescribing and a focus of antimicrobial stewardship (AMS) programs. A prospective audit at Austin Health has shown inpatient oral rechallenge led to 95.2% of patients with a documented penicillin allergy successfully had their penicillin AAL removed.

Journal of Antimicrobial Chemotherapy, 2019.

Previous Not all that it seems
Next Royal Commission: Pharmacy’s Biggest Opportunities

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.